Business
Solésence Reports Record First Quarter 2025 Financial Results
First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2025. Recent Highlights and Accomplishments Uplisted to Nasdaq under the ticker “SLSN” supporting the Company’s increased visibility with the investment communityAchieved record revenu
About this update from Solesence, Inc.
[{"type":"image","alt":"Solésence, Inc.","displaySize":"","headline":null,"caption":"Solésence, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":298,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/7f0b5f2aae8717562a59d4f306203102"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/64kg3V8qClp.MepqE2o0pQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7f0b5f2aae8717562a59d4f306203102","width":298,"height":300}},"lazy":false},{"type":"text","content":"First quarter revenue increased 48% to a record $14.6 million","length":61,"tagName":"p"},{"type":"text","content":"ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2025. ","length":266,"tagName":"p"},{"type":"text","content":"Recent Highlights and Accomplishments","length":37,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Uplisted to Nasdaq under the ticker “SLSN” supporting the Company’s increased visibility with the investment community","length":118,"tagName":"p"}]},{"val":[{"type":"text","content":"Achieved record revenue and unit volume shipments in the first quarter 2025","length":75,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":193,"olType":false},{"type":"text","content":"“We kicked off 2025 with record revenue, fueled by strong sales across our suite of consumer products,” said Jess Jankowski, President and Chief Executive Officer of Solésence. “Large customer orders, including a new product line with a key new brand partner, are driving growth and expanding our partnerships with leading beauty and health brands. As always, our relentless focus remains on delivering unique, high-performance products that enrich consumers’ daily lives and reinforce Solésence’s position as a trusted innovation partner.”","length":540,"tagName":"p"},{"type":"text","content":"“During the first quarter, we significantly increased our throughput to execute a multi-SKU launch for a new strategic brand partner. While this process resulted in one-time start-up costs that impacted our gross margins for the quarter, our operational flexibility and expertise enabled us to support ou...